As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...
On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...
“[T]he Third Circuit found that CMS’ treatment of six [Novo Nordisk] products as a single drug was ultimately precluded by the IRA’s bar against judicial review.” Yesterday, the U.S. Court of Appeals ...
At her home in Longwood, Fla., retiree Donna Weiner shows some of the daily prescription medications that cost her over $6,000 a year through a Medicare prescription drug plan on Oct. 5, 2021. (AP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback